Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design
Authors:
- Aziz SheikhASAziz Sheikh
- Colin Richard SimpsonCSColin Richard Simpson
- Tristan MillingtonTMTristan Millington
- Ting ShiTSTing Shi
- Utkarsh AgrawalUAUtkarsh Agrawal
- Safraj Shahul HameedSHSafraj Shahul Hameed
- Elliott HallEHElliott Hall
- Igor RudanIRIgor Rudan
Top Cited Papers
Open Access
- 22 April 2022
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 22 (7) , 959-966
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- How bad is Omicron? What scientists know so farNature, 2021
- BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta VariantNew England Journal of Medicine, 2021
- Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) DatabaseInternational Journal of Epidemiology, 2021
- SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectivenessThe Lancet, 2021
- Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort studyThe Lancet, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKThe Lancet, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort studyBMJ, 2020
- Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.1987